PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $507,082 | -3.2% | 12,019 | -14.3% | 0.13% | -8.3% |
Q4 2022 | $523,890 | -66.5% | 14,019 | -52.5% | 0.14% | -67.4% |
Q3 2022 | $1,566,000 | +17.0% | 29,519 | +27.8% | 0.44% | +24.2% |
Q2 2022 | $1,339,000 | -60.8% | 23,097 | -50.4% | 0.36% | -56.4% |
Q1 2022 | $3,413,000 | -84.9% | 46,597 | -87.2% | 0.82% | +24.9% |
Q4 2021 | $22,609,000 | +2097.2% | 364,376 | +1599.0% | 0.65% | +184.3% |
Q3 2021 | $1,029,000 | -28.5% | 21,447 | -16.0% | 0.23% | -28.1% |
Q2 2021 | $1,439,000 | -7.3% | 25,547 | +2.0% | 0.32% | -14.9% |
Q1 2021 | $1,552,000 | – | 25,047 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |